Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
3626
Novo Nordisk
NVO
$205B
| $645K | ﹤0.01% |
27,438
+13,740
| +100% | +$316K |
|
3627
Caleres
CAL
$461M
| $644K | ﹤0.01% |
23,876
-9,377
| -28% | -$271K |
|
3628
PUT
ProShares VIX Short-Term Futures ETF
VIXY
$190M
| $643K | ﹤0.01% |
20
+15
| +300% | +$463K |
|
|
PMCS
3629
DELISTED
P M C SIERRA INC
PMCS
| $643K | ﹤0.01% |
91,812
-4,757
| -5% | -$34.8K |
|
3630
Celldex Therapeutics
CLDX
$3.35B
| $642K | ﹤0.01% |
3,566
+361
| +11% | +$78.7K |
|
3631
ProShares Ultra Russell2000
UWM
$248M
| $642K | ﹤0.01% |
34,228
+27,804
| +433% | +$577K |
|
3632
PUT
Arrowhead Research
ARWR
$12.1B
| $641K | ﹤0.01% |
+45,800
| New | +$626K |
|
3633
CALL
Cal-Maine
CALM
$3.87B
| $641K | ﹤0.01% |
14,400
+9,400
| +188% | +$373K |
|
3634
Evogene
EVGN
$10.3M
| $641K | ﹤0.01% |
4,933
| – | – |
|
|
CSR
3635
Centerspace
CSR
$939M
| $640K | ﹤0.01% |
9,150
-389
| -4% | -$32.7K |
|
3636
Crane NXT
CXT
$2.96B
| $640K | ﹤0.01% |
29,248
-31,176
| -52% | -$756K |
|
3637
CALL
OGE Energy
OGE
$9.71B
| $640K | ﹤0.01% |
17,300
+7,100
| +70% | +$261K |
|
|
3638
PUT
OGE Energy
OGE
$9.71B
| $640K | ﹤0.01% |
17,300
+7,100
| +70% | +$261K |
|
3639
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $639K | ﹤0.01% |
9,529
+5,548
| +139% | +$385K |
|
3640
PUT
Armstrong World Industries
AWI
$7.68B
| $638K | ﹤0.01% |
11,400
+2,800
| +33% | +$156K |
|
3641
Oaktree Specialty Lending
OCSL
$1.15B
| $638K | ﹤0.01% |
23,613
-28,000
| -54% | -$818K |
|
|
SNV
3642
DELISTED
Synovus
SNV
| $638K | ﹤0.01% |
27,732
-27,509
| -50% | -$660K |
|
|
AAN.A
3643
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $638K | ﹤0.01% |
26,507
+8,327
| +46% | +$200K |
|
3644
CALL
Pentair
PNR
$10.7B
| $637K | ﹤0.01% |
14,592
-8,190
| -36% | -$379K |
|
|
MTOR
3645
CALL
DELISTED
MERITOR, Inc.
MTOR
| $637K | ﹤0.01% |
63,700
+7,000
| +12% | +$91.1K |
|
|
EBIX
3646
PUT
DELISTED
Ebix Inc
EBIX
| $636K | ﹤0.01% |
45,400
-15,900
| -26% | -$221K |
|
3647
Benchmark Electronics
BHE
$2.89B
| $635K | ﹤0.01% |
28,875
-7,868
| -21% | -$191K |
|
3648
CALL
Microchip Technology
MCHP
$42.2B
| $635K | ﹤0.01% |
27,000
-30,200
| -53% | -$722K |
|
3649
PUT
Owens Corning
OC
$12.3B
| $635K | ﹤0.01% |
20,500
-5,300
| -21% | -$187K |
|
3650
Southwest Gas
SWX
$6.67B
| $635K | ﹤0.01% |
13,227
+939
| +8% | +$48K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.